Jane Street’s Trillium Therapeutics Inc. TRIL Stock Holding History

Jane Street’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-148,800	Closed	-$2.61M	–	11229
2021 Q3	$2.61M	Buy	148,800 +89,500	+151%	+$1.05M	﹤0.01%	3933
2021 Q2	$575K	Buy	59,300 +23,700	+67%	+$223K	﹤0.01%	6978
2021 Q1	$381K	Sell	35,600 -111,300	-76%	-$1.38M	﹤0.01%	7305
2020 Q4	$2.16M	Buy	146,900 +1,100	+0.8%	+$15.9K	﹤0.01%	3350
2020 Q3	$2.07M	Buy	145,800 +102,500	+237%	+$1.02M	﹤0.01%	2983
2020 Q2	$350K	Buy	43,300 +31,400	+264%	+$194K	﹤0.01%	5611
2020 Q1	$47K	Buy	+11,900	New	+$45K	﹤0.01%	5099

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jane Street's TRIL Position: Q4 2021 in Review

Jane Street sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 173,761 shares — an estimated $3.05M sold.

Jane Street first reported a position in TRIL in Q4 2016 and held it in 10 quarters. The position peaked at $3.05M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Jane Street reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 173,761 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.05M.
Jane Street first reported a position in Trillium Therapeutics Inc. in Q4 2016 and held it in 10 quarters.
Jane Street's Trillium Therapeutics Inc. position peaked at $3.05M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.